SLE - Systemic Lupus Erythematosus Clinical Trials
3 recruiting trials for SLE - Systemic Lupus Erythematosus. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGPhase 1 / Phase 2NCT06189157
MB-CART19.1 in Refractory SLE
This is a phase l/ll open-label, multicentre, interventional single-arm trial of MB-CART19.1 in patients with refractory SLE systemic lupus erythematosus. In the phase I part, a...
Sponsor: Miltenyi Biomedicine GmbHEnrolling: 293 locations
RECRUITINGNCT07056621
Does Belimumab Modify the Natural History of SLE? A Propensity Score-matched, Real-world Study
This will be a combined retrospective and prospective cohort study, that will evaluate the incidence of de novo Systemic Lupus Erythematosus major organ manifestations (defined as...
Sponsor: Biomedical Research Foundation, Academy of AthensEnrolling: 6841 location
RECRUITINGPhase 1NCT07177911
Safety and Efficacy Study of CC312 for Moderate to Severe SLE
This study is a randomized, double-blind, placebo-controlled Phase I clinical trial featuring single and multiple ascending doses. It is designed to evaluate the safety,...
Sponsor: CytoCares IncEnrolling: 321 location